Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection

Author： Wyatt Christina M   Klotman Paul E  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.5, Iss.2, 2006-03, pp. : 275-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Risk in Patients with HIV Infection: Impact of Antiretroviral Therapy

By Bente Magny Bergersen  

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 1971-1987

Adis International

Access to resources Recommend Favorite

Affective Disorders in Patients with HIV Infection: Impact of Antiretroviral Therapy

By Arendt Gabriele  

CNS Drugs, Vol. 20, Iss. 6, 2006-01 ,pp. : 507-518

Adis International

Access to resources Recommend Favorite

Salvage antiretroviral therapy in HIV infection

By Walmsley Sharon L   Loutfy Mona R  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 2, 2002-02 ,pp. : 81-90

Informa Healthcare

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Interleukin-2 as an Adjunct to Antiviral Therapy in HIV Infection

By Piscitelli S.C.  

Drug Safety, Vol. 22, Iss. 1, 2000-01 ,pp. : 19-31

Adis International

Access to resources Recommend Favorite

Cardiovascular risk associated with antiretroviral therapy in HIV-infected patients

By Calza Dr Leonardo   Manfredi Roberto   Chiodo Francesco  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 11, 2006-11 ,pp. : 1497-1516

Informa Healthcare

Access to resources Recommend Favorite